---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-26-000091"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2026-09-14T20:02:18+00:00"
generated_at: "2026-09-14T20:03:50.160707+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Emergent BioSolutions CEO presentation at H.C. Wainwright provides no new financial details

## Summary
- Joseph C. Papa, President and CEO, to present at H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026.
- Investor presentation furnished as Exhibit 99.1, titled 'Combating Public Health Threats for Communities Around the World'.
- No specific financial data, guidance, or operational updates appear in the furnished presentation.
- Filing is a Regulation FD disclosure with no other material corporate developments.

## SEC filing metadata
- accession: 0001367644-26-000091
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2026-09-14T20:02:18+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764426000091/0001367644-26-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764426000091/ebs-20260914.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-26-000091
- JSON: https://secwatch.observer/filing/0001367644-26-000091.json
- Plain text: https://secwatch.observer/filing/0001367644-26-000091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.